BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12014597)

  • 21. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
    Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
    J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.
    Poulton A
    Expert Rev Neurother; 2006 Apr; 6(4):551-61. PubMed ID: 16623654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlates of incident bipolar disorder in children and adolescents diagnosed with attention-deficit/hyperactivity disorder.
    Jerrell JM; McIntyre RS; Park YM
    J Clin Psychiatry; 2014 Nov; 75(11):e1278-83. PubMed ID: 25470092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bipolar disorder and attention-deficit/hyperactivity disorder comorbidity in children and adolescents: evidence-based approach to diagnosis and treatment.
    Miller S; Chang KD; Ketter TA
    J Clin Psychiatry; 2013 Jun; 74(6):628-9. PubMed ID: 23842014
    [No Abstract]   [Full Text] [Related]  

  • 25. Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy.
    Mohammadi M; Akhondzadeh S
    Acta Med Iran; 2011; 49(8):487-98. PubMed ID: 22009816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Stimulants in Bipolar Disorder.
    Perugi G; Vannucchi G; Bedani F; Favaretto E
    Curr Psychiatry Rep; 2017 Jan; 19(1):7. PubMed ID: 28144880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attention Deficit Hyperactivity Disorder in Athletes.
    Ciocca M
    Clin Sports Med; 2019 Oct; 38(4):545-554. PubMed ID: 31472765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adult ADHD: clinical aspects and therapeutic implications].
    Ceraudo G; Vannucchi G; Perugi G; Dell'osso L
    Riv Psichiatr; 2012; 47(6):451-64. PubMed ID: 23160106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adults with ADHD. An overview.
    Wender PH; Wolf LE; Wasserstein J
    Ann N Y Acad Sci; 2001 Jun; 931():1-16. PubMed ID: 11462736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder.
    Bond DJ; Hadjipavlou G; Lam RW; McIntyre RS; Beaulieu S; Schaffer A; Weiss M;
    Ann Clin Psychiatry; 2012 Feb; 24(1):23-37. PubMed ID: 22303520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder.
    Chacko A; Pelham WE; Gnagy EM; Greiner A; Vallano G; Bukstein O; Rancurello M
    J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):249-57. PubMed ID: 15725969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (For).
    Isaacs D
    J Paediatr Child Health; 2006 Sep; 42(9):544-7. PubMed ID: 16925542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulant-atypical antipsychotic interaction and acute dystonia.
    Benjamin E; Salek S
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):510-2. PubMed ID: 15908830
    [No Abstract]   [Full Text] [Related]  

  • 36. Update on long-term stimulant medication treatment of attention-deficit hyperactivity disorder.
    Barbaresi WJ
    J Dev Behav Pediatr; 2014 Sep; 35(7):446-7. PubMed ID: 25180894
    [No Abstract]   [Full Text] [Related]  

  • 37. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M; Uekermann J; Wiltfang J; Kis B
    Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attention-deficit/hyperactivity disorder and substance abuse.
    Harstad E; Levy S;
    Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian motor activity affected by stimulant medication in children with attention-deficit/hyperactivity disorder.
    Ironside S; Davidson F; Corkum P
    J Sleep Res; 2010 Dec; 19(4):546-51. PubMed ID: 20629940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attention deficit/hyperactivity disorder across the lifespan.
    Wilens TE; Biederman J; Spencer TJ
    Annu Rev Med; 2002; 53():113-31. PubMed ID: 11818466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.